Evolve Biosystems Stock

Evolve BioSystems is developing the next generation of products to establish, restore, and maintain a healthy newborn gut microbiome.

Sign up today and learn more about Evolve Biosystems Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

Founded

2011

Notable Investors

Bill & Melinda Gates Foundation

Headquarters

Davis CA, US

Total Funding

$69.0M

About Evolve Biosystems Stock

Evolve Biosystems is a spin-out from the Foods For Health Institute (FFHI) at the University of California, Davis. The company builds on more than a decade of research into the infant biome and its intimate interaction with breast milk components established by the founding scientists including Bruce German, David Mills, Carlito Lebrilla, Daniela Barile and Samara Freeman. Their fundamental research and translational clinical trials have been enabled by more than $15 million in federal and private grants since 2004.

Investors

Funding History

August 2015$9.0M
May 2017$20.0M
June 2018$40.0M

Management

Director, IP & Regulatory Affairs

Samara Freeman

Co-Founder

Carlito Lebrilla

CEO

David Kyle

Co-Founder

Bruce German

Co-Founder

David Mills

Co-Founder

Daniela Barile

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo